Healthcare

KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…

5 months ago

KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…

5 months ago

Infinx Invests in Maverick AI to Bring Real-Time Autonomous Medical Coding to Revenue Cycle Management

Strategic Partnership Combines Maverick's GenAI-Powered Autonomous Agents With Infinx's Deep RCM Expertise to Accelerate Coding Accuracy CUPERTINO, CALIFORNIA / ACCESS…

5 months ago

Infinx Invests in Maverick AI to Bring Real-Time Autonomous Medical Coding to Revenue Cycle Management

Strategic Partnership Combines Maverick's GenAI-Powered Autonomous Agents With Infinx's Deep RCM Expertise to Accelerate Coding Accuracy CUPERTINO, CALIFORNIA / ACCESS…

5 months ago

TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab

SPARKS, MD / ACCESS Newswire / August 13, 2025 / TridentCare, the leading national provider of portable diagnostic services, has…

5 months ago

TridentCare Closes Acquisition of Shoreline Diagnostics, Solidifying Its California Presence With a Market-Leading Clinical Lab

SPARKS, MD / ACCESS Newswire / August 13, 2025 / TridentCare, the leading national provider of portable diagnostic services, has…

5 months ago

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

– Initiated Phase 2 Seabreeze STAT asthma and COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations –…

5 months ago

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

– Initiated Phase 2 Seabreeze STAT asthma and COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations –…

5 months ago

SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.

COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned…

5 months ago

SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.

COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned…

5 months ago
Show more Posts
Show previous Posts